The Value of PET-CT in Pleural Effusions
NCT03272997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112
Last updated 2020-12-17
Summary
The investigators aim is to asses the diagnostic power of 18F-FDG PET-CT in discriminating malignant from nonmalignant causes in patients with a recurrent unilateral pleural effusion of unknown origin.
Conditions
- Pleural Effusion, Malignant
Sponsors & Collaborators
-
Naestved Hospital
lead OTHER
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-01
- Primary Completion
- 2018-01-31
- Completion
- 2019-01-30
Countries
- Denmark
Study Locations
More Related Trials
-
18F-FSPG PET/CT Imaging in Patients With Cancers
NCT03144622 ·Status: UNKNOWN
-
18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma
NCT01610544 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Role of 18F-FDG-PET/CT Scan in Lung Cancer Patients
NCT04395651 ·Status: UNKNOWN
-
Efficiency of the Imaging Strategy for the Management of Pneumonia
NCT05140408 ·Status: UNKNOWN
-
18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot Study
NCT03352037 ·Status: COMPLETED ·Phase: NA
-
Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo
NCT02273271 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB
NCT02972697 ·Status: UNKNOWN ·Phase: PHASE1
-
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
NCT07087080 ·Status: RECRUITING ·Phase: NA
-
18F-Pentixafor PET in Hematologic Malignancies
NCT07122674 ·Status: RECRUITING
-
Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation
NCT03312712 ·Status: UNKNOWN
-
PET With Respiratory Gating Technique in Evaluation of Response and Normal Tissue Effect in Thoracic Cancer
NCT02063633 ·Status: UNKNOWN
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
Lung Nodule Detection Using Ultra-long FOV PET/CT
NCT05463913 ·Status: RECRUITING ·Phase: PHASE4
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study
NCT06747299 ·Status: NOT_YET_RECRUITING
-
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma
NCT03051555 ·Status: UNKNOWN ·Phase: NA
-
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer
NCT02995889 ·Status: COMPLETED ·Phase: NA
-
4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
NCT03568799 ·Status: UNKNOWN ·Phase: NA
-
PET/CT-Based Image Analysis and Machine Learning of Hypermetabolic Pulmonary Lesions
NCT06602674 ·Status: COMPLETED
-
Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy
NCT00725387 ·Status: COMPLETED
-
A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma
NCT06277206 ·Status: COMPLETED
-
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
NCT00004138 ·Status: COMPLETED ·Phase: NA
-
Response Evaluation in Malignant Pleural Mesothelioma
NCT00969098 ·Status: UNKNOWN
-
Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging System
NCT01030497 ·Status: COMPLETED
-
18 Fluoro-deoxy-glucose Positrons Emission Tomography Combined With Computed Tomography (18-FDG TEP-CT ) in the Diagnosis of the Degeneration of Intraductal Papillary Mucinous Tumor of the Pancreas
NCT01485679 ·Status: COMPLETED ·Phase: NA